Gloux, K., Guillemet, M., Soler, C., Morvan, C., Halpern, D., Pourcel, C., . . . Gruss, A. (2017). Clinical Relevance of Type II Fatty Acid Synthesis Bypass in Staphylococcus aureus. Antimicrob Agents Chemother.
Stile di citazione ChicagoGloux, Karine, Mélanie Guillemet, Charles Soler, Claire Morvan, David Halpern, Christine Pourcel, Hoang Vu Thien, Gilles Lamberet, e Alexandra Gruss. "Clinical Relevance of Type II Fatty Acid Synthesis Bypass in Staphylococcus Aureus." Antimicrob Agents Chemother 2017.
Citazione MLAGloux, Karine, et al. "Clinical Relevance of Type II Fatty Acid Synthesis Bypass in Staphylococcus Aureus." Antimicrob Agents Chemother 2017.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.